Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) will release its second quarter 2026 financial results after the market close on Monday, August 3, 2026. Management will host a conference call at 5:00 p.m. Eastern Time, with access via webcast and phone registration links.

News Market Reaction – INSP

+5.32%

7 alerts

+5.32% Session close to close

$1.35B Market Cap

0.6x Rel. Volume

In the Jul 6 session, INSP gained 5.32%, reflecting a notable positive market reaction. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +5.3% in the session following this news. A strong upside move following this Q2 202...

Analysis

The stock moved +5.3% in the session following this news. A strong upside move following this Q2 2026 earnings date notice would contrast with prior same-tag news, where average reactions were only about 0.16%. Elevated short positioning and recent insider net selling could still inject future volatility.

Key Figures

Q2 2026 release date: August 3, 2026 Earnings call time: 5:00 p.m. Eastern Time Pre-call registration window: 10 minutes +2 more

5 metrics

Q2 2026 release date August 3, 2026 Second quarter 2026 financial results release after market close

Earnings call time 5:00 p.m. Eastern Time Start time of Q2 2026 conference call

Pre-call registration window 10 minutes Suggested minimum time to register before call start

Replay availability delay 2 hours Approximate time after event when replay is posted

Replay archive duration 2 weeks Length of time call replay remains on Investor Relations site

Previous Earnings date Reports

2 past events · Latest: Apr 06 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 06	Earnings date notice	Neutral	-1.6%	Announced Q1 2026 earnings release timing and accompanying conference call logistics.
Jan 07	Earnings date notice	Neutral	+1.9%	Set date and time for Q4 and full year 2025 earnings release and call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings date notices produced small, mixed share reactions with no clear directional pattern.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, August 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2026 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q2 2026 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems (NYSE: INSP) report Q2 2026 financial results?

Inspire Medical Systems will report Q2 2026 financial results after the market close on Monday, August 3, 2026. According to the company, the release will be followed by a management conference call at 5:00 p.m. Eastern Time.

What time is the Inspire Medical Systems (INSP) Q2 2026 earnings conference call?

The Inspire Medical Systems Q2 2026 earnings call starts at 5:00 p.m. Eastern Time on August 3, 2026. According to the company, management will discuss financial results and recent business developments during the call.

How can investors access the Inspire Medical Systems Q2 2026 earnings webcast?

Investors can access the Inspire Medical Systems Q2 2026 earnings webcast via the Investor Relations page on the company’s website. According to Inspire, a direct webcast link is also provided for listeners who do not plan to ask questions.

How do I register to ask questions on the Inspire Medical Systems (INSP) Q2 2026 call?

To ask questions, investors must register using the specific Inspire Medical Systems Q2 2026 earnings call link. According to the company, registrants receive an email with dial-in details and a unique access code for the live call.

Will a replay be available for the Inspire Medical Systems Q2 2026 earnings call?

Yes, a replay of the Inspire Medical Systems Q2 2026 earnings call will be available on the company’s Investor Relations website. According to the company, the replay appears about two hours after the event and remains archived for two weeks.